Source: Annual Congress 2005 - Systemic effects of OSA
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
R. Staats, P. Stoll, J. C. Virchow, M. Lommatzsch (Rostock, Germany). Rapid fall of brain-derived neurotrophic factor (BDNF) serum and plasma levels following sleep apnea treatment. Eur Respir J 2005; 26: Suppl. 49, 2303

Member's Comments

No comment yet.

Related content which might interest you: Serum and mucosal brain derived neurotrophic factor (BDNF) in severe obstructive sleep apnea syndrome (OSAS). Effects of CPAP treatment on BDNF serum levels. Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019 The expression of brain-derived neurotrophic factor in hippcocampal and serum of chronic obstructive pulmonary disease model rats Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Serum neurotrophin-3 and neurotrophin-4 levels are associated with asthma severity in children Source: Eur Respir J 2012; 39: 1035-1037 Year: 2012 Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Stage-dependent regulation of brain-derived neurotrophic factor and transforming growth factor-β1 in patients with COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Regulation of brain-derived neurotrophic factor (BDNF) during acute lower respiratory tract infections of the adult Source: Eur Respir J 2006; 28: Suppl. 50, 853s Year: 2006 Brain derived neurotrophic factor (BDNF) in airway hyperresponsiveness Source: Annual Congress 2008 - Airway cell biology Year: 2008 Plasma levels of vascular endothelial growth factor in children with sleep-disordered breathing Source: Annual Congress 2005 - Sleep apnoea in children Year: 2005 The impact of serum leptin and soluble leptin receptor (sOB-R) levels on respiratory chemosensitivities in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006 Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005 Serum adiponectin, hs- C-reactive protein and tumor necrosis factor-alpha levels In patients with obstructive sleep apnea syndrome: Effect of CPAP Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010 CPAP decreases elevated plasma levels of soluble tumor necrosis factor-α receptor 1 in OSAS patients Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002 Association of serum retinol-binding protein-4 (RBP4) levels and OSAS severity. Effect of long-term CPAP treatment Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Effect of inhalation exposure to an occupational allergen on sputum levels of brain-derived neurotrophic factor Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013 Association of IL-6 and TNFα and leptin receptor (LEPR) gene polymorphism with IL-6 and TNFα serum level in obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Ghrelin, leptin and adiponectin plasma levels in sleep apnea patients with and without excessive daytime sleepiness Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Autocrine expression of mechano and insulin-like 1 growth factors (MGF & IGF-1) in the diaphragm of severe COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 573s Year: 2003 Expression and role of the nerve growth factor NGF in pulmonary hypertension Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension Year: 2011 Nerve growth factor (NGF) gene polymorphism in allergic asthma Source: Annual Congress 2010 - Risk factors for allergic diseases in children Year: 2010